Most recent update: Friday, December 13, 2019 - 12:50

Bariatric News - Cookies & privacy policy

You are here

Patent issued

Obalon issued first US Patent for Navigation System

Expands the company’s intellectual property estate to 20 issued US patents

Obalon Therapeutics has announces the issuance of US Patent No. 10,264,995, entitled ‘Systems and methods for locating and/or characterizing intragastric devices’. The first of its kind Obalon Navigation System provides the treating physician with the ability to place the Obalon Balloon without having to incur the costs and inconvenience of utilising x-ray imaging, the company stated. The Obalon Navigation System is portable, easy to use, non-invasive and radiation free when placing the Obalon Balloon - the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity.

The newly issued patent covers multiple aspects of the Obalon Navigation System, including dynamic tracking using internal and external sensors with an external electromagnetic field.

“We have used Obalons’ prior generation EzFill balloon, liquid filled balloons, and now the Obalon Navigation System,“ said Dr Jeremias C Tan, Health and Wellness Services, Medical Director Gastroenterology Associates of Northern Virginia. “On average, Navigation balloon placements take about 15 minutes in our office. Automated inflation improves patient satisfaction and helps make placement of Navigation intragastric balloons more convenient for both the patient and the doctor. The Obalon Balloon System is a safe, effective and efficient solution for individuals with a BMI between 30 to 40 kg/m2 who are ready to lose weight and improve their overall health.”

Obalon now has 20 patents issued in the US and 31 patents issued internationally that cover the Obalon Balloon System, with 25 and 55 pending patent applications in the US and in international territories, respectively.

“We believe this patent provides protection against anyone else entering the market, either with a gas-filled or liquid-filled balloon, that wants to use a similar system to avoid the extra costs and considerable logistics of using x-ray during placement,” said Mark Brister, Obalon’s Chief Technology Officer.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.